Trial intelligence / Profile preview

WELCOME: Purified n-3 Fatty Acids in NAFLD

NCT00760513Phase 4Completed

Sponsor
University Hospital Southampton NHS Foundation Trust
Start
Nov 2009
Primary completion
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of omega-3-acid triglycerides in non-alcoholic fatty liver disease (NAFLD), sponsored by University Hospital Southampton NHS Foundation Trust. Started Nov 2009; status: completed.

02

Drugs

omega-3-acid triglycerides
03

Conditions

non-alcoholic fatty liver disease (NAFLD)

Beyond the preview

Go deeper on NCT00760513.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00760513.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call